Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source

Cryptogenic strokes constitute 20 to 30% of ischemic strokes, and most cryptogenic strokes are considered to be embolic and of undetermined source. An earlier randomized trial showed that rivaroxaban is no more effective than aspirin in preventing recurrent stroke after a presumed embolic stroke fro...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hans‐Christoph Diener, Ralph L. Sacco, J. Donald Easton, Christopher B. Granger, Richard A. Bernstein, Shinichiro Uchiyama, Jörg Kreuzer, Lisa Cronin, Otto W. Witte, Claudia Grauer, Martina Brueckmann, M. A. Chernyatina, Geoffrey A. Donnan, José M. Ferro, Martin Grond, Bernd Kallmünzer, Jerzy Krupiński, Byung‐Chul Lee, Robin Lemmens, Jaime Masjuán, Miroslav Odinak, Jeffrey L. Saver, Peter D. Schellinger, Danilo Toni, Ḱazunori Toyoda
Format: Artigo
Langue:anglais
Publié: 2019
Accès en ligne:https://doi.org/10.1056/nejmoa1813959
https://www.nejm.org/doi/pdf/10.1056/NEJMoa1813959?articleTools=true
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doi.org/10.1056/nejmoa1813959
https://www.nejm.org/doi/pdf/10.1056/NEJMoa1813959?articleTools=true

Documents similaires